We have located links that may give you full text access.
Case Reports
Journal Article
Persistent primary hypogonadism associated with anabolic steroid abuse.
Fertility and Sterility 2011 July
OBJECTIVE: To report a case of primary gonadal failure due to the chronic abuse of anabolic steroids used for bodybuilding.
DESIGN: Case report.
SETTING: Department of Diabetes and Endocrinology, Morriston Hospital, Swansea, Wales, United Kingdom.
PATIENT(S): A 40-year-old man.
INTERVENTION(S): None.
MAIN OUTCOME MEASURE(S): Clinical symptoms, levels of serum T, FSH, and LH.
RESULT(S): Primary gonadal failure resulting from anabolic steroid use.
CONCLUSION(S): We describe a case of initially secondary gonadal failure resulting from anabolic steroid use with subsequent primary gonadal failure and infertility. This case adds to the current literature and illustrates that the side effects of anabolic steroids can be prolonged and irreversible.
DESIGN: Case report.
SETTING: Department of Diabetes and Endocrinology, Morriston Hospital, Swansea, Wales, United Kingdom.
PATIENT(S): A 40-year-old man.
INTERVENTION(S): None.
MAIN OUTCOME MEASURE(S): Clinical symptoms, levels of serum T, FSH, and LH.
RESULT(S): Primary gonadal failure resulting from anabolic steroid use.
CONCLUSION(S): We describe a case of initially secondary gonadal failure resulting from anabolic steroid use with subsequent primary gonadal failure and infertility. This case adds to the current literature and illustrates that the side effects of anabolic steroids can be prolonged and irreversible.
Full text links
Related Resources
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app